Healthcare Value Capital »

Proshares Ultrapro Short S&p500 shares owned by Healthcare Value Capital

Quarter-by-quarter ownership of Proshares Ultrapro Short S&p500 (SPXU) shares owned by Healthcare Value Capital from 13F filings

Historical chart of Healthcare Value Capital investment in Proshares Ultrapro Short S&p500

Tip: Access up to 7 years of quarterly data

All positions including Proshares Ultrapro Short S&p500 held by Healthcare Value Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proshares Ultrapro Short S&p500 by Healthcare Value Capital

Quarter filed Position value Share count Share price at filing
2021-09-30 $2.6M 150k 17.54
2021-06-30 $911k 50k 18.22
2021-03-31 $2.4M 100k 23.68

More positions owned by Healthcare Value Capital

Alkermes SHS Put Option (ALKS)
Pfizer (PFE)
Gilead Sciences (GILD)
Glaxosmithkline Sponsored Adr
Amryt Pharma Sponsored Ads
Merck & Co (MRK)
Astrazeneca Sponsored Adr (AZN)
Bristol Myers Squibb (BMY)
Proshares Tr Ultrapro Short S Call Option (SPXU)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Clovis Oncology
Tyme Technologies
Antares Pharma
Proshares Tr Ultrapro Sht Qqq Call Option
Proshares Tr Ii Ultra Vix Short Call Option

View all positions for Healthcare Value Capital

Top funds holding Proshares Ultrapro Short S&p500

Susquehanna International
Citadel Advisors
Lane Generational
Hrt Financial
Axxcess Wealth Management
Tower Research Capital
Jump Financial
G. W. Henssler & Associates
Gts Securities
Jane Street
Morgan Stanley
Vima
Walleye Trading Advisors
Simplex Trading
WESPAC Advisors SoCal

View all funds holding Proshares Ultrapro Short S&p500